Philip Morris
Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
Fields
- Author
- Bickel, W.K.
- Higgins, S.T.
- Hughes, J.R.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Br.;uh Jourrtal o(Addu:mn (1990) 85, 441-445
REPORTS FROM RESEARCH CEN.-TRES-21
Human Behavioral Pharmacology Laboratory
University of Vermont
JOHN R. HUGHES, STEPHEN T. HIGGINS & WARREN K. BICKEL
The Human Behavioral Pharmacology Laboratory
(HBPL) is a utut of the Department of Psychiatry,
t'niversity of Vermont College of Medicine. The
unit began in 1987 and presently consists of a
psychiatrist (JRH), two psychologists (WKB,
STH), two postdoctoral fellows, three research
nurses and four graduate and two undergraduate
students in psychology. Our major sources of
funding are ten grants from the Vational Institute
on Drug Abuse, National Institute on Alcohol
Abuse and Alcoholism and National Heart, Lung
and Blood Institute plus two gnats from pharma-
ceuucal companies. These granu include First
Investigator Research Scientist Transition (STH),
Research Scientist Development (JRH), Young
Investigator (WKB), and National Research Service
(pre-doctoral) Awards plus a pre-doctoral fellow-
ship.
Our research typically uses the experimental
analysis of behavior to determine envtronmental,
biological and pharmacological factors that control
the self-administntion of and behavioral effects
from drugs of abuse. Our research spans several
classca of drugs. Presently we are studying alcohol,
amphetamines, benzodiazeptnes, cannabindmds,
caffeine, cocaine, nicotme and opioids. Most of our
research is human laboratory reseuch, with an
emphasis on behavioral rather than physiological or
biochemical outcomes. We often apply paradigms
from animal research to humans (e.g. concurrent
Requesu foc tapnats sDould be sddressed to: Joba R Hupes,
Deparsmeat of Psychuury, Uaverury of Vamoat, BurhWon, ~T
05405, USA.
access to drug and placebo to examine reinforcing
effects, repeated acquisition of behavioral chains to
examine learning and performance). Not tnfre-
quently our human laboratory work leads us to
clinical trials or epidemiological surveys to deter-
mine the stgnif cance and generaluabiliry of our
findings.
Our three major areas of research interest are the
direct effects of drugs, the reinforcing effects of
drugs, and treatment of drug abuse.
Direct effects of drup on behavior and
physiology
Ltarnmg and performance
Q'e have been assessing the effects of a variety of
abused drugs on human learamg and performance
using the Repeated Acquisition and Performance of
Response Chains procedure. This procedure perauts
a simultaneous comparison of drug effects on the
xquisition of behavior (i.e. learning) with effects
on the performance of previously learned behavior
(i.e. performance) using wtthin-sub}ect designs.
Although originally developed with nonhumans the
Repeated Acquuiuon and Performance procedure
has been usefully extended to the study of humans
as well. We have obtained dose-response relation-
ships on the acquisition of response chains under
both acute and chronic dosing reg:mens. Alcohoi,
barbiturates and the bentodiazepusrs consistently
disrupt buasan learning and performance when
relatively high doses are studied. Stimulants (e.g.
d-amphetanune) buspirone, and delta-9 THC
generally do not disrupt leartung or perfotmance,
441
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
442 John R. Hughes, Stephcn T. Higgtns & R'arren K. Bickel
although they do disrupt learnmg in some indivtdu-
als. Importantly, abused drugs disrupt learning at
low doses that do not disrupt performance. Compu-
isons with results from nonhumans indicates an
impressive degree of concordance.
Social interaction
Most drugs of abuse increase human social interac-
tion. R'e have been investigating whether such
effects occur because these drugs increase the
control exerted by social reinforcers. To test this we
use a two-choice concurrent schedule where normal
volunteen choose between socially interacting with
another same-se: volunteer versus earning money.
In this setting, d-amphetamtne increases choice for
social over monetary reinforcement. Preliminary
results indicate that secobarbital produces a similar
effect. These results are consistent with the notion
that some of the reinforcing effects of abused drugs
is associated with their ability to increase social
interaction.
Cardiac furtcnon
Recent studies have focused on the cardiac effects of
using stimulants (e.g. cocaine, d-amphetamtne)
alone and in combination with alcohol. Interestin-
gly, the cardiac effects of d-amphetamine are
enhanced when combined with alcohol. Thus, the
common practice of abusing drugs in combination
may increase risks of toxicity beyond the risks of
using these drugs alone.
Summary
Our work on direct effects of drugs makes a
contribution to behavioral pharmacology in that it
demonstrates (1) the generality of behavioral prtn-
csples across human and nonhuman behavior, (2)
the tntegration of findings using operant procedures
with those more traditional 'learning and memory'
tasks, (3) the influence of envuronmental factors
(i.e. acquisition versus performance) on the effects
of drugs on bunsan learning, and (4) the utility of
the Repeated Acquuttion and Performance proce-
dure in the detection of behavioral effects of
commonly used and abused drugs.
Reinforcing effects of drup
RetnJorctng effeur of nieowu
In placebo-controUed cliaical trials and on-site
laboratory studies, nicotine via nicotine gum often
induces long-term use. Self-admtntstrauon of aico-
ttne gum is controlled by cost to obtain nicotine,
dose, instructions, past drug history and setung.
Dose-response effects of nicotine gum appear to
vary by outcome (i.e. withdrawal relief versus
cessatton). The role of physical dependence (i.e.
withdrawal) in the reinforcing effects of nicotine is
not well examined. Our studies in smoking cessation
programs, medical practice and self-quttter popula-
uons have shown that cessation of tobacco produces
a reliable, observabie group of stgns and symptoms,
many of which are due to nicotine deprivation.
Dose, instructions, setting and subtect character-
istics, have been shown to influence the degree of
withdnwal. Surprisingly, in our studies, withdrawal
has not been shown to robustly influence smoking
cessation.
.
Reinforcing efjecu of caffeinr
In a series of double-blind tests, some coffee
drinkers given concurrent access to decaffeinated
coffees with and without caffeine quite reliably
show stgas of physical dependence and self-admin-
ister caffeinated coffee in preference to decaffein-
ated coffee. Doses as low as 25 mg (half of that
found in soda or tea) are reliably self-administered.
Survey studies indicate that a signi5cant minority of
coffee drinkers fulfill DSM-111-R criteria for de-
pendence when applied to coffee use. Future studies
plan to examine factors tbat might determine
whether coffee is used for the effects of caffeine
(e.g. sleep deprivation) and to examine the ability of
subjects to discriminate low doses of caffeine. Our
labontory and survey studies indicate that removal
of caffeine from coffee produces reliable wtthdrawal
symptoms (e.g. headaches, drowsiness and fatigue)
that can, at times, be severe. Importantly, the
occurrence of such effects appears to be associated
with the reinforcing effects of caffeine.
Treatment studies
Treatmntr of xiconne drpendencs
In a large study in general practice, nicotine gum
was not found to iacrease quit rates over placebo
when used with brief physician advice and in
unselected smokers. We are presently conducting a
study of 2 versus 4 mg nicotine gum and of a
nicotine patch.
I

I
I
I
I
I
I
1
I
I
I
I
I
I
I
I
I
I
Human Behatnora! Pharmcology Labaratorv Untoerrtty of Vmnont 443
Tfearmn+t of coca:nc abusr
aCe are presently embarking on a series of studies to
assess the efficacy of behavioral interventions for
treating cocaine dependence. The studies will assess
whether a behavioral intervention involving com-
munity reinforcement of abstinence and basic con-
tingency management procedures is more effective
than standard alcohol and drug counselling. Subse-
quently, we will experimentally assess the ef5cacy
of the different components of our behavioral
interventton, Finally, we will assess whether com-
bined behavioral and pharmacological therapy (e.g.
destpramtne treatment) significantly enhances out-
come above what is achieved with either alone.
Other areaa of interest
.bfethodologieal studies
We have conducted empirical
different procedures to assess
studies to examine
reinforcing effects,
methods to increase recruitment and follow-up in
clinical studies, and measures of nicottae with-
drawal.
77seorerual work
We are interested in conceptual issues such as the
role of stimulus control in both drug self-admuus-
trauon and in the direct effects of drugs, the factors
that influence the verbal behavior of scientists,
definitions of drug withdrawal and dependence, and
combining behavioral and pharmacological treat-
ments for substance abuse.
Future studies
At this point, we have no plans to change our focus
or types of activities. We do plan to expand our
training of postdoctoral sad graduate students.
There are two research areas that will be of special
interest to us in the future. The first is the
development and testing of a human drug discrtmt
nation procedure for sedative-hypnoucs. The sec-
ond is the application of behavioral economics to
quantify reinforcing effects of drugs, to study drug
interactions, and to study bow non-drttg reinforcers
nttght decrease drug intake. Our first study on
cigarette and coffee use demonstrated the utility of
such an economic conceptualization.
Further informarioa
We publish a semt-annual report in April and
October that list recent publications. To obtain the
report and reprints wrtte Human Behavioral Phar-
macoiogy Laboratory, Depattment of Psychiatry,
University of Vermont College of Medicine,
Burlington, VT 05405.
Bibliography
The following is a list of our published articles in
the last year.
BtcxEt., W. K., Biost.ow, G. E., PRzrrox, K. L. &
LtEUON, I. A. (1989) Opsoid drug discnminauoa Ln
humans: stability, spect5ctry and relauoa to self-
reported drug effect, Jorrnal of Pharnsacology
G
EzpenrRmtd lheraprsutcs, 251, pp. 1053-1063.
BtcT.Et., W. K. & HiGGINs, S. T. (1989) Acqutsttton and
performance of response chains: modulauon by envtroa-
mental and pharmacolopcal factors, Pharwsacolaly,
Buxhhnutry ard Bekaflsor, 29 p. 657.
Btcxat., W. K., HtcGirs, S. T. & Gwrmu, R. R. (1989)
Repeated duzepam administration: Effects on the
acquisition and performance of response chams in
humans, Yournai of the Ezpertswsrsta! Arsdyru of &ka-
tno+, 52, pp. 42-45.
Btcitat, W. K., Hluaixs, S. T., Kautr, K. & JoHrtsoN, L.
M. (1989) Effects of schedule history and >ued-rauo
requirement on fited-usterval schedule performance,
Joumal of t1u Espersru" .4nalyru of Behavso+, 50,
pp. 211-218.
Btcrut., W. K., Hiuctxs, S. T., GttLtss, M. & Huans,
J. R. Effects of trtuolam and buspuone on the
icquisiuon and performance of response chuas in
humans, in: L. S. HNtlus (Ed.) P*oblestu of Drug
Depessdesce, 1988, N1DA Reuarch Monod.aph (Wuh-
cngton, DC, US Goverameat Pnnuag Office) p. 318.
BtcstEL, W. K., HIGGIxs, S. T. & Huaias, J. R. (1990)
Human behsvioral phumacotop of beazodazeptnes as
assessed by the repeated acquisition of behavioral
chauns, Drug Developrnenr Research (in press).
BtesCiL, W. K. 8 KitzY, T. H. (1988) The relauonship of
stimulus control to the tttatment of substance abuse, in:
B. RAr (Ed.) Lsams,Y Factort ur Subuai+ce Abuse
(Washiniton D.C., National Institute on Drug Abuse)
pp. 122-140.
BtcuW. K., Srrrau, M. K., Bton.a., G. E., Lmsox,
1.A., Jtisnrstu, D. R. A Jornvson, R. E. (1989)
Buproaorphaae: dose-related blocksde of opioid chal-
leap effects in opod dependent humaas, Josnwal of
Pha++Raco/o& & F-sper-s,tal Therapeuata, 247, Pp-
47-53.
Btcui, W. K., KxsoKr, W. F., PatdAGtosot+us, P.,
Ktatxrr, R., K!-osea, J., 2au.ortT, R. D., Mrwot+, 1. &
Lowrxsort, J. H. (1989) Combined behasoral aad
pharmacological treatment of alcoholic methadone pa-
uents, Josnwa/ oJ Sybsrsnu Abssse, 1, pp. 161-171.
HetsvL+au, D. K., DNa-awr, L, Ztwuauur, K. !~
HuotQs, J. R. (1988) Symptoms of tob.eeo wtthdrawal
frm total csgarette cessation vs parual ciprette redtx-
uoa. PryckopAarwuzcoloV, 94, pp. 242-247.
Harstrsuxt, D. K., Ptcgmts, R. p., Svtus, D. S. k
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
1
444 John R, Hughes, Stephen T. Htggtns G IT'arren K. Bsckrl
HL'GHES, J R. (1988) Smoking topogzapbv and blood
nicotine ieveis, Addictive Behar:o+s, 13, pp 91-96.
HEN NINGFiELD, J E. & HIGGINS, S. T (1989) On the
in9uence of behaviora! research: a response to the
Surgeon General's report, The Health Consequences of
SmoKing: Nicotine Addiction', The Behavior Asalys4
;:, pp 99-101.
HIGGIsS, S. T., CAfELESS, M., HCGHES, J. R. & BEL7NSON,
M Behavioral and cardiovascular effects of alcohol and
damphe:amme conbinations in normal volunteers, in:
L. S. HA1uus ( Ed. ) 1'roblems of Dru6 Dependence, 1988,
.`'IDR Research .Nonog+aph, 90, pp.35-36, (Washsng-
toa, DC US Government Printing OfSce).
HIGG1Ns, S. T., HEvNiNGFIELD,J. E. & LAnU,R. J. (1989)
Behavioral and physiological effects of atropine in
norttul volunteers, PhanRacoloV, Biochemusry & Be-
hatno., 34, pp. 303-311.
HIGGIHS, S. T., B1cxFS., W. K., HUGHES, J. R., RusH, C.
R., PEPPEIt, S. & LrNtr, M. (1989) Comparable rates of
responding and reinforcement do not elsmsnate the
differential effects of ethanol on response chain acquisi-
tion and performance, T),e Prycholohcal Record, 39, pp.
583-595.
HtoGt.s, S. T., HUGHES, J. R. & GAUaGHEIt, R, yi.
(1988) Introducing the unfamsl3ar to behavioral phar-
macologti~ a review of pnmen by A. Poling and P. L.
Carlton, The Beharto* Malyst, 10, pp. 277-281.
H1oG1Ns, S. T., Koaus, E. K. & JoHNSON, L. K. (1989)
Social traasussssioa of superstitious behavior in pre-
school children, Prycholohca/ Record, 39, pp. 307-323.
HtGGtxs, S. T., PteESroN, K., CANE, E., HEwxr.+GrgLD, J.
E. & JAFFEE, J. (1988) Behavioral, phystolopcal and
hormonal effects of a nalosone challenge following
acute morphine pre-treatment in humaas, in: L. S.
HAStltss (Ed.) Problems of Dnug Dependence, 1987,
:JIDA Research Monoaraph 81, pp. 202-208 (Washaag-
ton, DC, US Goverament Prmung Offlce).
H1GGtNS, S. T. & SrrtZElt, M. L. (1989) :Konolo`ue
speech: effects of d-amphetamsne, secobarbttal and
dsuepam, PharmacoloV, Bioclsemurry & Behatnor, 34,
pp. 609-618.
HtGGtNs, S. T. & StTTZF.It, M. L. (1990) Companson of
tbe effects of secobarbital and diazepam on the acqutsi-
uoa of response sequences in humaas, D*v8 Develop-
mens Research, 10, pp. 317-398.
HtGGtxs, S. T. & StnZl?&,K. L. (1988s) Time allocation
in a concurrent schedule of soual tnteracuoa and
moaeur7 reinforcement: Effects of d-amphetaaune,
Phar+nacotoV, B»chensttry, as.d Bskcmor, 31, pp.
227-231.
HtGGets, S. T. & STrrzEit, M. L. (1988b) Effects of
alcobol on speaktng sn ssolated subpects, PryclsopAm>aea-
colopr, 95, pp. 189-194.
Htacros, S. T., Wooa.AitD, B. M. & HENxt:'+GFrzLD, J. E.
(1989) Time-coune of the effects of atsoptne on
repeated scqtuutsoa and performance of response se-
quences in hamaas, Journal of elu Erpenme+ssal .lnaty-
su of BeMavsor, 51, pp. 5=15.
Htcctlvs, S. T., HuGms, J. R. & Btcul., W. K. (1989)
Effects of d-ampbeumsne on cbou:e of soctal rerstu
monetary resafoesemeat: a dsscrete-rrsai test, Pkama-
coloV, Bioclsen<ssrry & Beheetor, 34, pp. 297-301.
HUGHES, J. R., Axotu, G. & HATSU><Axt, D. (1988) Free
reprnnts to increase the return of follow-up quesuon-
nures: a repitcatton test, Amertcan Journal of Public
Health, 77, pp. 1474-1475.
HL'GHES, J. R. (1988) Clowdine, depression and smoking
cessation, Journal of the .lsrsericaR .Nedccal .4ssoaasson,
254,pp,2901-2902.
HCGHES, J. R. (1989a) Preveauag relapse of the e:-
smoker: the show must go on, Journa/ of the Amertcan
Medical Assoctanon ( ia press ).
HUGHES, J. R. (1989b) Ce1a n'etast pas une couverrure,
Joumal of theAme+tcan Medual Assoctaton, 261, p. 2956.
Ht:GHES, J. R., AMOSU, G., HATSL'xAAU, D. K. & LwtGNE,
F. (1988) A survey of phvstcun advice about caffeine,
Journal of Substance Abuse, 1, pp. 67-70.
HuGHES, J. R. (1989) Eavironmental determinants of the
reinforcing effects of nicotine, Journal of Substance
Abuse, 1, pp. 319-329.
HUGHES, J. R., ARANA, G., Sh.AttT, F. & WosuAUlr, R.
(1988) Effect of tobacco wuhdnwal on the dezamethr
soae suppression test, Btolortcal Prych:arry, 23, pp.
96-98.
HUGHES, J. R., BICxEL, W. K. & HIGGtxs, S. T. (1989)
Successful tnnsfer to buprenorphsne m a patient on
morphine, tn: L. S. HAttlus (Ed.) P+oblems of Dne6
Dependence, 1988, NIDA Research Monor*aph, p. 357
(Washsngton, DC, US Government Printing OfSce).
HuoHEs, J. R., Gcu.>ZM S. B., AA+au, G., Nsn>:.+vLT, G.
& FE*tsx'.>t, J. (1990) Effect of instructions and
nicotine on smoksng cessation, withdrawal symptoms
and self-admsnsstrauon of nscoune gum, Prychopharma-
colo&, 99, pp. 486-491.
HuGHS, J. R., Gus-r, S. W., KEENAN, R. K., FErmC><, J.
W. Et HLt1.t', 4t. L. (1989) Nicotine vs piacebo gum tn
general practice, Journai of du Amertcan Medical
dssocusnon, 261, pp. 1300-1305.
Ht:GHFs, J. R. & HATSU>tAAU, D. K. (1984) Free repnats
to increase retusa of follow-up quesuoanaues, Behavior
Tknapy, 15, pp. 557-558.
HUGHES, J. R., HlGCms, S. T. & B1cxaL, W. K. (1989)
Behavioral 'properues' of drugs, PrychopharmacoloV,
96, pp. 557.
HUGHES, J. R., HtGGtxs, S. T. & HATSVxAxt, D. K.
(1990) Effect of abstinence from tobacco, in: L. T.
KozLo.stu, H. Axxu, H. D. CArr=u- et al. (Eds)
Research Advances tn Akohol and Drug Probienu, 10,
pp. 31 7-398 (New York, Pleaum Press).
HUGHES, J. R., KEENAS+, R. & YFJ-t.114, A. (1988) Effect of
tobacco withdrawal on sustuned attention, Addscate
Behavsors, 14, pp. 577-580.
JOMN30H, L. M., Blc>tl!J-, W. K., Hsootxs, S. T. &
MosUtts, E. K. (1990) The effects of scbedule hsstory
and avaslabWty of an adluncta.e response on responduig
dursag a Szed-uster.al scbeduk of tesnforsement,
Joumal of the EEspersnsensal Analysts of Behavso+ (us
press ).
Kllur, K. C. & Btcx>ri, W. 1C (1989) Toward an explicit
analysis geaerahzauon: a stsmulus control Laterpreta-
tson, Tke Behaoso+al Anatys; 11, pp. 115-129
KorrLl:, T. E., Buxu, M. L., SocsatG, L. I. & HUGHES,
J R. (1989) A raadomszed trtal to mcrease smoksa;
intervention by pbysicuns: Doctors Helpusg Smokers,
Round I, Jou.ral of the Aiwencros Medaca/ Auoc+aaon,
26, pp. 2101-2106.
Loetsmno, T. W., Huatas, J. R. & Ftcou, J. D. (1988)
Failure to suppvrt the .aLdst7 of the Faterstsom

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Xumcn Behavtosai Pharmcology LaboratorS L'ntvenuy of Vermont
Tolenace Quesuoanure as a me2sure of pbvsiotogual
toierance to dependeace, Addicttve Behav:ors, 13, pp
8%-90
POME1tLfaL', 0., POMERLEAt.',C., FAGERSTROM, K0 ,
HEN-,'tNGFtELD, J E, & HLGHES, J. R. (1988) J'icottne
Replacement en the Treatment of Snsoktng (New Y'ork,
Alan Goldstein).
445
PREStoti, K. L., B1GELow, G. E., BtacaL R' K. &
L1EDSOV, I. A. (1988) Drug ducnmtaauon tn human
postaddtcts. mued agonistantagontsts, in: L. S. HAIt
RlS (Ed ) Probltmt of Drug Dependence, 1987, pp.
209-215 (Washington D.C., Vauonai Instttvte on Drug
Abuse).
I
